La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Ping An Healthcare and Technology Crescita futura
Future criteri di controllo 3/6
Ping An Healthcare and Technology prevede che gli utili e i ricavi cresceranno rispettivamente di 42.9% e 8.6% all'anno. Si prevede che l'EPS crescerà di 39.8% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 0.9% in 3 anni.
Informazioni chiave
55.5%
Tasso di crescita degli utili
54.4%
Tasso di crescita dell'EPS
| Consumer Retailing crescita degli utili | 28.2% |
| Tasso di crescita dei ricavi | 6.5% |
| Rendimento futuro del capitale proprio | 0.9% |
| Copertura analitica | Good |
| Ultimo aggiornamento | 28 Aug 2024 |
Aggiornamenti recenti sulla crescita futura
Recent updates
Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Not Quite Adding Up
Jul 17
Revenues Not Telling The Story For Ping An Healthcare and Technology Company Limited (HKG:1833)
Apr 17Ping An Healthcare and Technology (HKG:1833) Is In A Strong Position To Grow Its Business
Mar 20Calculating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 12Getting In Cheap On Ping An Healthcare and Technology Company Limited (HKG:1833) Is Unlikely
Dec 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Sep 27A Look At The Intrinsic Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 10When Should You Buy Ping An Healthcare and Technology Company Limited (HKG:1833)?
Aug 02Here's Why We're Not Too Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Situation
Jun 26Ping An Healthcare and Technology Company Limited's (HKG:1833) Share Price Could Signal Some Risk
Jun 07Is There An Opportunity With Ping An Healthcare and Technology Company Limited's (HKG:1833) 46% Undervaluation?
Apr 04Should You Think About Buying Ping An Healthcare and Technology Company Limited (HKG:1833) Now?
Feb 16We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Jan 23A Look At The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Jan 02Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Oct 11Estimating The Fair Value Of Ping An Healthcare and Technology Company Limited (HKG:1833)
Sep 14Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Jun 22We're Hopeful That Ping An Healthcare and Technology (HKG:1833) Will Use Its Cash Wisely
Mar 01We're Not Very Worried About Ping An Healthcare and Technology's (HKG:1833) Cash Burn Rate
Nov 13Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Oct 18Companies Like Ping An Healthcare and Technology (HKG:1833) Are In A Position To Invest In Growth
Aug 05Are Ping An Healthcare and Technology Company Limited (HKG:1833) Investors Paying Above The Intrinsic Value?
Jul 10We Think Ping An Healthcare and Technology (HKG:1833) Can Afford To Drive Business Growth
Apr 04If You Had Bought Ping An Healthcare and Technology (HKG:1833) Shares A Year Ago You'd Have Earned 47% Returns
Feb 28Are Institutions Heavily Invested In Ping An Healthcare and Technology Company Limited's (HKG:1833) Shares?
Jan 24
We Think Ping An Healthcare and Technology (HKG:1833) Can Easily Afford To Drive Business Growth
Dec 29Does This Valuation Of Ping An Healthcare and Technology Company Limited (HKG:1833) Imply Investors Are Overpaying?
Dec 03Previsioni di crescita degli utili e dei ricavi
| Data | Ricavi | Guadagni | Flusso di cassa libero | Liquidità dell'operazione | Avg. Numero di analisti |
|---|---|---|---|---|---|
| 12/31/2026 | 5,599 | 261 | 252 | 518 | 12 |
| 12/31/2025 | 5,378 | 189 | 122 | 261 | 13 |
| 12/31/2024 | 4,545 | 118 | 75 | 69 | 13 |
| 6/30/2024 | 4,545 | -21 | -387 | -351 | N/A |
| 3/31/2024 | 4,609 | -172 | -356 | -317 | N/A |
| 12/31/2023 | 4,674 | -323 | -326 | -283 | N/A |
| 9/30/2023 | 5,135 | -370 | -577 | -536 | N/A |
| 6/30/2023 | 5,596 | -418 | -829 | -789 | N/A |
| 3/31/2023 | 5,901 | -527 | -837 | -800 | N/A |
| 12/31/2022 | 6,205 | -636 | -845 | -811 | N/A |
| 9/30/2022 | 6,276 | -879 | -1,042 | -992 | N/A |
| 6/30/2022 | 6,347 | -1,121 | -1,239 | -1,174 | N/A |
| 3/31/2022 | 6,841 | -1,330 | -1,366 | -1,288 | N/A |
| 12/31/2021 | 7,334 | -1,538 | -1,492 | -1,403 | N/A |
| 9/30/2021 | 7,636 | -1,576 | -1,319 | -1,232 | N/A |
| 6/30/2021 | 7,938 | -1,614 | -1,145 | -1,060 | N/A |
| 3/31/2021 | 7,402 | -1,281 | -1,160 | -1,081 | N/A |
| 12/31/2020 | 6,866 | -948 | -1,175 | -1,102 | N/A |
| 9/30/2020 | 6,203 | -812 | -822 | -730 | N/A |
| 6/30/2020 | 5,539 | -675 | -469 | -358 | N/A |
| 3/31/2020 | 5,302 | -704 | -553 | -431 | N/A |
| 12/31/2019 | 5,065 | -734 | -637 | -504 | N/A |
| 9/30/2019 | 4,777 | -737 | -856 | -682 | N/A |
| 6/30/2019 | 4,488 | -740 | -1,075 | -859 | N/A |
| 3/31/2019 | 3,913 | -826 | -1,179 | -972 | N/A |
| 12/31/2018 | 3,338 | -912 | -1,283 | -1,085 | N/A |
| 9/30/2018 | 3,082 | -1,182 | -1,125 | -1,007 | N/A |
| 6/30/2018 | 2,542 | -990 | -866 | -827 | N/A |
| 3/31/2018 | 2,205 | -996 | N/A | -655 | N/A |
| 12/31/2017 | 1,868 | -1,002 | N/A | -484 | N/A |
| 9/30/2017 | 1,319 | -641 | N/A | -531 | N/A |
| 12/31/2016 | 601 | -758 | N/A | -263 | N/A |
| 12/31/2015 | 279 | -324 | N/A | -45 | N/A |
Previsioni di crescita futura degli analisti
Guadagni vs tasso di risparmio: Si prevede che 1833 diventerà redditizio nei prossimi 3 anni, il che è considerato una crescita più rapida del tasso di risparmio ( 2.3% ).
Guadagni vs Mercato: Si prevede che 1833 diventerà redditizia nei prossimi 3 anni, il che è considerato una crescita superiore alla media del mercato.
Guadagni ad alta crescita: Si prevede 1833 diventerà redditizia nei prossimi 3 anni.
Ricavi vs Mercato: Si prevede che il fatturato di 1833 ( 7% all'anno) crescerà più lentamente rispetto al mercato Hong Kong ( 7.4% all'anno).
Ricavi ad alta crescita: Si prevede che il fatturato di 1833 ( 8.6% all'anno) crescerà più lentamente di 20% all'anno.
Previsioni di crescita dell'utile per azione
Rendimento futuro del capitale proprio
ROE futuro: Si prevede che il Return on Equity di 1833 sarà basso tra 3 anni ( 0.6 %).